INFO & CONTACTS:  +39 02 2390 1
Cicchetti

Cicchetti Alessandro

Researcher

Contacts
  • Mail: alessandro.cicchetti@istitutotumori.mi.it
Specialty / Department
  • Medical Physics

He is a researcher and Group Leader at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. He has a background in medical physics and holds a PhD in physics applied to medicine, with a specialization in radiobiology. His work lies at the intersection of oncology, medical physics and data science, aiming to translate clinical and imaging data into tools for more personalized cancer care.

His research focuses on developing and validating predictive models to estimate treatment outcomes, identify toxicity risks and support clinical decision-making. Cardio-oncology is a major area of interest, particularly the cardiovascular effects of radiotherapy and systemic anticancer treatments, quantitative image analysis and the integration of multimodal data.

He leads Location Matters, a multicenter project funded by Fondazione AIRC that investigates radiation doses delivered to individual cardiac structures and their association with clinical outcomes after thoracic radiotherapy. He is also Co-Principal Investigator of RAPID Solution, which applies artificial intelligence to breast cancer radiotherapy planning, and leads modeling analyses within BIONCARD, a project investigating cardiovascular and oncological biomarkers associated with anti-VEGF and anti-VEGFR therapies.

He contributes to international scientific initiatives and working groups, including those of the European Society for Radiotherapy and Oncology (ESTRO) and Cancer Core Europe (CCE), fostering multidisciplinary collaboration between quantitative research and clinical practice.

Data Science

LOCATION MATTERS Project: Improving the success rate for thoracic radiotherapy through specific cardiac substructure dosimetry

RAPID Solution, Optimizing RAdiotherapy Planning: an AI-Driven Solution for Breath-Hold Selection in Breast Cancer

BIONCARD, Identifying surrogate oncological outcome biomarkers: a translational study of anti-VEGF/TKI-induced cardiovascular effects in pan-cancer cohort patients

Last update: 17/11/2026

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe